Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Gestational Diabetes and Intrauterine Growth Restriction"
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Obstetrics and Gynecology".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 1412
Special Issue Editors
Interests: gynecologic oncology; endometrial cancer; cervical cancer; ovarian cancer; vulvar cancer; cytoreductive surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue in Journal of Clinical Medicine: Clinical Outcome and Management of Gynecological Malignancies
Special Issue in Cancers: Neoadjuvant and Adjuvant Therapy for Gynecologic Malignancies
Special Issue in Cancers: Perioperative Care in Gynecologic Oncology
Interests: maternal-fetal medicine; intrauterine growth restriction; preeclampsia; preterm birth
Special Issue Information
Intrauterine growth restriction and gestational diabetes are two of the most common pathologic entities encountered during the antenatal period and account for approximately 10-15% of pregnancies. Gestational diabetes is a significant risk factor that predisposes patients to intrauterine fetal growth restriction through a variety of pathophysiological processes, examples of which include epigenetic alterations, impaired cholesterol metabolism, placental vasculopathy, etc. Significant advances have been achieved in the last decade; however, research is still needed to elucidate the pathophysiology of both pregnancy complications in order to help achieve optimal maternal and neonatal antenatal outcomes.
In the present issue, we hope that leading experts will share their perspectives on the pathophysiology of gestational diabetes and intrauterine growth restriction and that they will contribute to current knowledge with novel evidence that provides the foundation for further research.
We seek contributions in the form of original research articles, reviews, or shorter perspective articles on all aspects related to the subject. Topics may include but are not limited to epigenetic and genetic modifications, altered protein profiles, ultrasonographic markers, and environmental factors that predispose patients to the occurrence of gestational diabetes and/or intrauterine growth restriction.
Dr. Vasilios Pergialiotis
Prof. Dr. George Daskalakis
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gestational diabetes
- fetal growth restriction
- pregnancy complications
- large for gestational age